title: Biochemical prognostic indicators for pancreatic neuroendocrine tumors and small bowel neuroendocrine tumors.
abstract: Pancreatic neuroendocrine tumors (PNETs) and small bowel neuroendocrine tumors (SBNETs) are rare tumors that are frequently diagnosed late in the course of the disease. Several biomarkers have been proposed in the literature as prognostic factors for patients with these tumors. This article discusses a recent publication in Annals of Surgical Oncology from the University of Iowa analyzing the effect of different biomarkers on survival in patients with PNETs and SBNETs.
authors.affiliation: Department of Surgical Oncology, Baylor University Medical Center, 3410 Worth Street, Suite 235, Dallas, Texas 75246, USA.
authors.forename: Christine S
authors.initials: CS
authors.lastname: Landry
authors.affiliation: Department of Surgical Oncology, Baylor University Medical Center, 3410 Worth Street, Suite 235, Dallas, Texas 75246, USA.
authors.forename: Keith
authors.initials: K
authors.lastname: Cavaness
authors.affiliation: Department of Surgical Oncology, Baylor University Medical Center, 3410 Worth Street, Suite 235, Dallas, Texas 75246, USA.
authors.forename: Scott
authors.initials: S
authors.lastname: Celinski
authors.affiliation: Department of Surgical Oncology, Baylor University Medical Center, 3410 Worth Street, Suite 235, Dallas, Texas 75246, USA.
authors.forename: John
authors.initials: J
authors.lastname: Preskitt
keywords: 5-hydroxyindoleacetic acid (5-HIAA); Pancreatic neuroendocrine tumors (PNETs); chromogranin A (CgA); neurokinin A; neuron specific enolase; pancreastatin; pancreatic polypeptide; serotonin; small bowel neuroendocrine tumors (SBNETs)